[Short report on the possibilities of an immunosuppressive treatment in pulmonary diseases].
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000477:Alkylating Agents / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000150:complications; D001215:Asparaginase / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008171:Lung Diseases / Q000188:drug therapy*; D010396:Penicillamine / Q000627:therapeutic use; D011658:Pulmonary Fibrosis / Q000188:drug therapy
D000305:Adrenal Cortex Hormones; D000477:Alkylating Agents; D000963:Antimetabolites; D007166:Immunosuppressive Agents; D003609:Dactinomycin; D001215:Asparaginase; D010396:Penicillamine
Kurzer Erfahrungsbericht über Möglichkeiten einer immunosuppressiven Therapie bei Lungenkrankheiten